1. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary
- Author
-
Raul Pellini, Maria Benevolo, Renato Covello, Ferdinando Marandino, Francesca Rollo, Barbara Pichi, and Maria Gabriella Donà
- Subjects
Male ,0301 basic medicine ,Pathology ,medicine.medical_specialty ,Histology ,Cytodiagnosis ,Biopsy, Fine-Needle ,Lymphadenopathy ,Malignancy ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,Cytology ,medicine ,Humans ,Papillomaviridae ,Lymph node ,Aged ,Aged, 80 and over ,medicine.diagnostic_test ,Squamous Cell Carcinoma of Head and Neck ,business.industry ,Papillomavirus Infections ,Head and neck cancer ,virus diseases ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,Oropharyngeal Neoplasms ,030104 developmental biology ,Fine-needle aspiration ,Oropharyngeal Neoplasm ,medicine.anatomical_structure ,Lymphatic Metastasis ,030220 oncology & carcinogenesis ,DNA, Viral ,Neoplasms, Unknown Primary ,Female ,Lymph Nodes ,business ,Neck - Abstract
Objective Cervical lymph node fine needle aspirates (FNAs) may represent the only specimens available for an initial characterisation of patients with lymphadenopathy. Morphology and human papillomavirus (HPV) DNA presence were evaluated in FNAs collected from patients with oropharyngeal squamous cell carcinoma (OPSCC) or cancer of unknown primary (CUP). FNA HPV results were compared with those of the respective formalin-fixed paraffin-embedded (FFPE) primary cancer. Methods Liquid-based cytology was performed on FNAs collected in PreservCyt. HPV-DNA was analysed by the INNO-LiPA HPV genotyping Extra II on both cytological and FFPE samples. The CINtec® Histology Kit was used to assess p16 expression in cancer tissues. Results Forty-seven FNAs were collected from OPSCC and 16 from CUP patients. Cancer cells were found in 35/47 cases (74.5%), while 11 (23.4%) showed only necrosis and one (2.1%) was negative for malignancy. HPV-DNA was detected in 30/47 FNAs (63.8%), mostly harbouring HPV16 (90.0%). An excellent agreement was observed between the FNA and corresponding FFPE HPV status (raw agreement: 97.5%; Cohen κ: 0.94). The HPV test result on the necrotic FNAs completely matched that of the respective primary cancer. FNA HPV testing correctly identified 26/27 HPV-driven OPSCCs (96.3%). HPV was detected in nine of 16 FNAs (56.2%) from CUP patients. Conclusions HPV status of metastatic cervical lymph node FNAs reflects that of the corresponding primary OPSCCs even when cell integrity in the FNA is not preserved and only necrotic debris are present. In patients with initial CUP, HPV-positivity on the FNA may guide the diagnostic workup and therapeutic management, since it suggests an oropharyngeal origin.
- Published
- 2018
- Full Text
- View/download PDF